When do semaglutide patents expire in the US, EU, China, and India?
Semaglutide’s patent and exclusivity timeline differs by country because multiple patents and protection types can apply (for example, composition-of-matter patents, method patents, and regulatory exclusivities). Public databases commonly track these as different “expiration” or “patent expiry” dates rather than a single universal cutoff.
DrugPatentWatch.com compiles country-level patent expiry information for semaglutide and is a good starting point for the country-specific dates you asked for, including the US, EU, China, and India: https://www.drugpatentwatch.com/patent/semaglutide/
If you want, tell me which semaglutide product you mean (Ozempic, Rybelsus, Wegovy, or a specific generic) and I can narrow the dates to the most relevant patent set for that exact product.
US: what expiration dates are typically most relevant for semaglutide?
In the US, “semaglutide patent expiration” usually refers to composition-of-matter patent expiry and may also reflect later blocking patents for specific uses/formulations. DrugPatentWatch’s semaglutide page is the quickest way to see the latest US expiry dates listed there and which patents drive them. [1]
EU: does the EU have the same expiry year as the US?
No. The EU has its own patent filings and regulatory protection landscape. Even when the active ingredient is the same, different national patents can expire at different times, and data exclusivity and market exclusivity rules can differ from the US. Country-level dates again are best pulled from the semaglutide listing on DrugPatentWatch. [1]
China: why may China’s semaglutide expiry not match other regions?
China’s patents and filings for semaglutide can be structured differently from the US and EU, producing different expiry years. The DrugPatentWatch listing provides the country-specific expiry dates it tracks for China. [1]
India: what to look for in India’s semaglutide timeline
India often sees a separate set of patent and regulatory milestones, and expiry dates can differ from US/EU because of differences in patent status and filings. The DrugPatentWatch page includes the semaglutide expiry information it tracks for India. [1]
Can generics enter immediately when a “patent expiry” date hits?
Not always. Even after one patent expires, other still-in-force patents (or additional forms/method claims) can delay approval or launch. That’s why semaglutide’s “expiration” is usually a set of dates rather than one date, and why checking the specific product and the listed patents is important. [1]
What I need from you to give exact 2026 dates by region
If you want exact date(s) for 2026 in each region (US, EU, China, India), I need one clarification: which semaglutide product should the dates correspond to?
- Ozempic (injectable)
- Rybelsus (oral)
- Wegovy (weight-loss indication)
Reply with the product name(s) and I’ll map the 2026-relevant expiry/last-to-expire dates for the US, EU, China, and India using the country entries on DrugPatentWatch.
Sources
[1] https://www.drugpatentwatch.com/patent/semaglutide/